Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.

During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typic...

Full description

Bibliographic Details
Main Authors: Eli B Nix, Joshua Choi, Christina Anthes, Gabrielle N Gaultier, Joelle Thorgrimson, Andrew D Cox, Raymond S W Tsang, William G McCready, Douglas Boreham, Marina Ulanova
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6093645?pdf=render
id doaj-f5b186e643ef4ec7a8e8c5001ba1a445
record_format Article
spelling doaj-f5b186e643ef4ec7a8e8c5001ba1a4452020-11-25T01:46:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020128210.1371/journal.pone.0201282Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.Eli B NixJoshua ChoiChristina AnthesGabrielle N GaultierJoelle ThorgrimsonAndrew D CoxRaymond S W TsangWilliam G McCreadyDouglas BorehamMarina UlanovaDuring the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. CONCLUSIONS:The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease.http://europepmc.org/articles/PMC6093645?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Eli B Nix
Joshua Choi
Christina Anthes
Gabrielle N Gaultier
Joelle Thorgrimson
Andrew D Cox
Raymond S W Tsang
William G McCready
Douglas Boreham
Marina Ulanova
spellingShingle Eli B Nix
Joshua Choi
Christina Anthes
Gabrielle N Gaultier
Joelle Thorgrimson
Andrew D Cox
Raymond S W Tsang
William G McCready
Douglas Boreham
Marina Ulanova
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
PLoS ONE
author_facet Eli B Nix
Joshua Choi
Christina Anthes
Gabrielle N Gaultier
Joelle Thorgrimson
Andrew D Cox
Raymond S W Tsang
William G McCready
Douglas Boreham
Marina Ulanova
author_sort Eli B Nix
title Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
title_short Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
title_full Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
title_fullStr Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
title_full_unstemmed Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
title_sort characterization of natural bactericidal antibody against haemophilus influenzae type a in canadian first nations: a canadian immunization research network (cirn) clinical trials network (ctn) study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. CONCLUSIONS:The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease.
url http://europepmc.org/articles/PMC6093645?pdf=render
work_keys_str_mv AT elibnix characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT joshuachoi characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT christinaanthes characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT gabriellengaultier characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT joellethorgrimson characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT andrewdcox characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT raymondswtsang characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT williamgmccready characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT douglasboreham characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
AT marinaulanova characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy
_version_ 1725018917277007872